51 related articles for article (PubMed ID: 7039203)
21. The effects of dopaminergic blocking agents on the glucose tolerance test in 6 humans and 6 dogs.
Lechin F; Coll-García E; van der Dijs B; Bentolila A; Peña F; Rivas C
Experientia; 1979 Jul; 35(7):886-7. PubMed ID: 477842
[TBL] [Abstract][Full Text] [Related]
22. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors.
Pucak ML; Grace AA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1181-92. PubMed ID: 7996424
[TBL] [Abstract][Full Text] [Related]
23. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
[TBL] [Abstract][Full Text] [Related]
24. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
Miczek KA; Fish EW; De Bold JF; De Almeida RM
Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
[TBL] [Abstract][Full Text] [Related]
25. Dopamine and distal colon motility.
Lechin F; van der Dus B
Dig Dis Sci; 1979 Jan; 24(1):86-7. PubMed ID: 428298
[No Abstract] [Full Text] [Related]
26. [Stereoisomers of sulpiride and dopamine: interaction on kidney function in humans].
Agnoli GC; Cacciari M; Cariani A; Garutti C; Ikonomu E; Lenzi P
Cardiologia; 1983 Jun; 28(6):489-508. PubMed ID: 6687180
[No Abstract] [Full Text] [Related]
27. [Dopaminergic receptors in the gastrointestinal tract].
Kurtz W
Klin Wochenschr; 1988 Mar; 66(5):225-6. PubMed ID: 3361799
[No Abstract] [Full Text] [Related]
28. [Clinical pharmacology and therapeutic results of a specific antagonist in disorders of gastroduodenal and peripheral motility].
Bertrand J; Thillier JL
Sem Hop; 1980 Oct 18-25; 56(39-40):1579-81. PubMed ID: 6255572
[No Abstract] [Full Text] [Related]
29. The peripheral dopaminergic system. Basic and clinical advances.
Am J Hypertens; 1990 Jun; 3(6 Pt 2):1S-2S. PubMed ID: 1974437
[No Abstract] [Full Text] [Related]
30. [Action of sulpiride on intestinal motility].
Marone G; Lobello R; Marzano LA; Colantuoni A
Boll Soc Ital Biol Sper; 1974 Dec; 50(23-24):2074-9. PubMed ID: 4464918
[No Abstract] [Full Text] [Related]
31. Pharmacomanometric studies of colonic motility as a guide to the chemotherapy of schizophrenia.
Lechin F; van der Dijs B; Gomez F; Valls JM; Acosta E; Arocha L
J Clin Pharmacol; 1980; 20(11):664-71. PubMed ID: 7229114
[TBL] [Abstract][Full Text] [Related]
32. [Pectins. Present state of knowledge].
Seyrig JA; Naveau S; Gonzales R; Petit R
Gastroenterol Clin Biol; 1983 Dec; 7(12):1031-7. PubMed ID: 6662323
[No Abstract] [Full Text] [Related]
33. Effects of dopaminergic blocking agents on distal colon motility.
Lechin F; Van Der Dijs B
J Clin Pharmacol; 1979 Oct; 19(10):617-25. PubMed ID: 512059
[TBL] [Abstract][Full Text] [Related]
34. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Dhir A; Kulkarni SK
Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
[TBL] [Abstract][Full Text] [Related]
35. Dopamine: pharmacologic and therapeutic aspects.
Velasco M; Luchsinger A
Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
[TBL] [Abstract][Full Text] [Related]
36. [The role of dopamine in the gastrointestinal tract and its relation to intestinal peptides].
Castells Molina S; Rodríguez Méndez SA
Med Clin (Barc); 1988 Jan; 90(1):28-32. PubMed ID: 3279275
[No Abstract] [Full Text] [Related]
37. Intestinal pharmacomanometry and glucose tolerance: two kinds of dopaminergic mechanisms in the human.
Lechin F; van der Dijs B
Acta Gastroenterol Latinoam; 1981; 11(2):247-59. PubMed ID: 7039203
[TBL] [Abstract][Full Text] [Related]
38. Intestinal pharmacomanometry and glucose tolerance: evidence for two antagonistic dopaminergic mechanisms in the human.
Lechin F; van der Dijs B
Biol Psychiatry; 1981 Oct; 16(10):969-86. PubMed ID: 7306619
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
